Investment Rating - The report maintains a "Buy" rating for the company with a target price of HK$ 1.95, reflecting a downward adjustment from the previous target of HK$ 2.85 [1]. Core Insights - The company experienced a disappointing revenue growth of 8% in the first half of 2024, with a further decline in gross margin to 15.9% and net profit margin dropping to 3.4% [1]. - Revenue growth was the lowest since 2021, primarily due to weak performance in the automotive market, which negatively impacted the company's key revenue segments: new energy and intelligent driving [1]. - Despite the increasing penetration rate of new energy vehicles, intense price competition has compressed profit levels for upstream participants, limiting growth potential for the company [1]. - The report indicates that the company needs to enhance pricing and offer upgraded product combinations to achieve significant improvement, although a major turnaround is unlikely before downstream price wars improve [1]. - Positive signals for recovery are anticipated in 2025, with new solutions expected to contribute significantly to profits by 2026 [1]. Summary by Sections Financial Performance - Revenue for 2024 is projected at RMB 6,277.2 million, with a year-on-year growth of 8.2% [5]. - Gross profit is expected to be RMB 1,002.7 million, with a gross margin of 16.0% [5]. - Net profit is forecasted to decline by 31.9% to RMB 212.9 million in 2024 [5]. Market Position - The company holds a market capitalization of approximately HK$ 1.3 billion [1]. - The report highlights the competitive landscape, noting that the average price-to-earnings ratio for similar companies is significantly higher, indicating potential undervaluation [2]. Future Outlook - The company is expected to see initial recovery in 2025, with profit margins normalizing by 2026 as new solutions are launched [1]. - The anticipated increase in the proportion of self-produced batteries by GAC is expected to bring more orders to the company [1].

股 票 研 究 海 外 公 司 （ 中 国 香 港 ） 证 券 研 究 报 告 国泰君安版权所有发送给上海东方财富金融数据服务有限公司.东财接收研报邮箱.ybjieshou@eastmoney.com p1 医院业务稳健发展，床位扩张有序推进 海吉亚医疗(6078) [Table_Industry] 医药 [Table_Invest] 评级： 增持 ——2024 年中报点评 股票研究 /[Table_Date] 2024.09.03 | --- | --- | --- | |----------|-----------------------------------|-----------------------| | | [table_Authors] 丁丹 ( 分析师 ) | 赵峻峰 ( 分析师 ) | | | 0755-23976735 | 0755-23976629 | | | dingdan@gtjas.com | zhaojunfeng@gtjas.com | | 登记编号 | S0880514030001 | S0880519080017 | 本报告导读： 内生外延共同发力，上半年收入快速增长， ...

Investment Rating - Buy (Maintained) [1] Core Views - The company's Q2 2024 gross margin exceeded expectations, reaching 11%, which was above the upper guidance of 10% [3] - The semiconductor cycle is showing signs of moderate recovery, driven by a rebound in consumer electronics demand [1][4] - The company's capacity utilization rate reached 98% in Q2 2024, with expectations to remain high through 2025 [5] - The company's second 12-inch production line is progressing smoothly, with trial production expected by the end of 2024 and full capacity by Q1 2025 [5] Financial Performance - Q2 2024 revenue was $480 million, down 24% YoY but up 4% QoQ [3] - Net income attributable to shareholders was $70 million, down 92% YoY and 79% QoQ, primarily due to a shift from tax credits in Q1 2024 to tax expenses in Q2 2024 [3] - Revenue from consumer electronics, industrial & automotive, communications, and computers in Q2 2024 was $290 million, $110 million, $60 million, and $10 million respectively, with consumer electronics showing a 4% QoQ increase [4] - Embedded memory and discrete device revenues in Q2 2024 were $140 million and $150 million respectively, up 15% and 6% QoQ [4] Capacity and ASP - The company's 8-inch equivalent ASP in Q2 2024 was $432.7, down 26% YoY and 4% QoQ, but expected to rise in H2 2024 due to price increases in logic, RF, CIS, and embedded memory [5] - The company expects Q3 2024 revenue to be between $500 million and $520 million, with 70% of the growth driven by ASP increases and 30% by additional shipments [5] Financial Forecasts - Revenue for 2024E, 2025E, and 2026E is projected to be $1,982 million, $2,493 million, and $3,044 million respectively [2] - Net income attributable to shareholders for 2024E, 2025E, and 2026E is forecasted to be $83.95 million, $104.93 million, and $165.84 million respectively [2] - The company's P/B ratio for 2024E, 2025E, and 2026E is estimated to be 0.58, 0.57, and 0.56 respectively [2] Market Data - The closing price on September 2, 2024, was HKD 16.70, with a P/B ratio of 4.57 [6] - The company's market capitalization was HKD 21,875.37 million [6] Financial Ratios - ROE for 2024E, 2025E, and 2026E is projected to be 1.32%, 1.63%, and 2.53% respectively [10] - Gross margin for 2024E, 2025E, and 2026E is expected to be 10.75%, 18.54%, and 19.88% respectively [10]

即时点评 销气毛差持续修复，中期派息大幅增长 华润燃气（1193 HK） 2024-09-02 星期一 事件： 截至 2024 年 6 月 30 日止六个月，公司实现营业收入 520.8 亿港元， 同比增加 7.7%。股东应占净利润为 34.57 亿港元，同比减少 2.5%，剔 除去上半年同期重庆燃气并表产生的一次性收益影响后，公司核心利 润为 34.6 亿港元，同比增长 21.2%；上半年公司经营现金流 42.5 亿港 元，公司拟派中期股息 25 港仙/股（2023 上半年：10 港仙/股）。 相关报告 点评观点： ➢ 上半年总销气量同比增长 5.3%，销气毛差持续修复： 上半年，公司总销气量 209.0 亿立方米，同比增长 5.3%，其中工业气 量增长 3.7%，商业气量增长 8.1%，居民气量增长 7.0%；期内增加年 度合同指标量 7.5 亿方，新年度气源合同覆盖率增至 99.7%，统筹气 量 17.5 亿方，同比增长 30%，并补充非常规资源超 2 亿方，公司多元 化气源结构有利进一步优化上游采购成本；上半年公司销气毛差 0.54 元/方，同比增加 4 分/方，公司全年销气毛差指引为 0.53-0. ...

理想汽车（LI.O/2015.HK） 更新报告 | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | |-------|-------------------------------------------------------------------------------------------------------------------------------------------------|----------------------------------------|------------------------------|--------------------------|---------|-------------------------------------------|---------------|---------------|---------------------------------------| | | | 买入 | | | | | | | 2024 年 9 月 3 日 | | | 智 ...

Investment Rating - The report maintains an "Accumulate" rating for the company [1][3] Core Views - The company reported a revenue of 2.93 billion HKD for the first half of 2024, representing a year-on-year increase of 11.9%, while the net profit attributable to shareholders was 310 million HKD, a decrease of 13.8% year-on-year [3] - The recovery of third-party business has been noted, with significant growth in the Chinese compound seasoning and convenience food segments [3] - The company plans to distribute a dividend of 293 million HKD, achieving a dividend payout ratio of 95%, which is expected to boost investor confidence [3] Summary by Sections Revenue and Profitability - The company achieved a revenue of 2.93 billion HKD in 1H24, up 11.9% year-on-year, with third-party business revenue reaching 1.91 billion HKD, an increase of 12.2% [3] - The gross margin for 1H24 was 30.0%, a slight decrease of 0.5 percentage points year-on-year, primarily due to raw material cost fluctuations [3] - The net profit margin decreased by 3.0 percentage points to 11.4% due to increased sales expenses [3] Business Segments - Hot pot seasoning revenue was 1.75 billion HKD, up 5.6% year-on-year, with sales volume increasing by 21.4% [3] - Chinese compound seasoning revenue reached 450 million HKD, a growth of 24.4%, driven by new product launches [3] - Convenience food revenue was 700 million HKD, up 22.2%, with significant growth from both related and third-party sales [3] Future Projections - Revenue forecasts for 2024-2026 are adjusted to 6.81 billion HKD, 7.64 billion HKD, and 8.40 billion HKD, with growth rates of 10.8%, 12.1%, and 10.0% respectively [4] - Net profit projections for the same period are 829 million HKD, 967 million HKD, and 1.08 billion HKD, with year-on-year changes of -2.9%, +16.6%, and +12.0% [4] - The expected earnings per share (EPS) for 2024-2026 are 0.80 HKD, 0.93 HKD, and 1.04 HKD, with corresponding price-to-earnings (PE) ratios of 13.3X, 11.4X, and 10.2X [4]

中国民航信息网络（696） 更新报告 | --- | --- | --- | |-------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|---------------------------------| | 买入 \n受益于民航业需求回暖，业绩恢复增长 | 李宜格 | 2024 年 9 月 3 日 | | 业 绩 符合预期 ： 2024 年 上 半 年 公司收入 40.4 亿元人民币 | 852-25321962 | | | （ YoY+22.2% ）,归属于母公司股东净利润 13.7 亿元（ YoY+13.9% ），主要 | | Vicky.li@firstshanghai.com.hk | | 是受益于民航运输业需求回暖，系统处理旅客量恢复增长所致。公司每股 | 罗凡环 | | | 盈利为人民币 0.47 ...

港股通 证券研究报告 上美股份 (2145 HK) 韩束 X 肽系列重磅发布，新增长极可期 投资评级(维持): 买入 目标价(港币): 59.93 研究员 樊俊豪 SAC No. S0570524050001 SFC No. BDO986 fanjunhao@htsc.com +(852) 3658 6000 研究员 孙丹阳 SAC No. S0570519010001 SFC No. BQQ696 sundanyang@htsc.com +(86) 21 2897 2038 华泰研究 动态点评 2024 年 9 月 01 日│中国香港 化妆品 韩束新品"超频 X 肽系列"重磅发布，产品矩阵再延伸，后续值得期待 24 年 8 月 30 日公司主品牌韩束推出全新 X 肽系列重磅新品 X 肽超频霜， 定位"涂抹美容仪"。X 肽是公司继环六肽-9 之后的又一重磅成分，通过模 拟光电射频原理将抗衰深入皮肤内部，实现深层抗老。灵魂成份+数据验证 +清晰卖点，X 肽系列具备成为强消费者认知的大单品的卖相。24M1-M7 韩 束淘系/抖音 GMV 分别为 36.1/5.0 亿，抖音权重更大、天猫增速快而体量 有限，以套盒销 ...

证 券 研 究 报 告 请务必阅读免责条款 | --- | --- | --- | |---------------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ...

2 期试验获得积极疗效，且耐受性良好。2024 年 5 月，临床 3 期试验方案已 获得 FDA 批准。 证券研究报告 | 公司动态点评 2024 年 09 月 02 日 来凯医药-B（02105.HK） ATK 抑制剂乳腺癌 3 期启动，ActRIIA 顺利进入临床 | --- | --- | --- | --- | --- | --- | --- | --- | |--------------------------------------------------------------------------------|--------------------------------------------------------|----------------------------|------------------------|------------------------------------------|--------------|--------------------------------------------|------------------| | 财务指标 | 20 ...